免疫酚/犬尿氨酸多克隆抗体/IS1011
市场价：
¥7400.00
美元价：
3700.00
联系Q Q：
3392242852
电话号码：
4000-520-616
电子邮箱：
info@ebiomall.com
商品介绍
| Product information | Protocols | References | Technical support | Reviews |
Product overview
| Product name | Kynurenic acid polyclonal antibody |
| Synonyms | Kinurenic acid polyclonal antibody 4-Hydroxyquinoline-2-carboxylic acid polyclonal antibodyKYNA polyclonal antibody |
| Immunogen | Conjugated kynurenic acid |
| Specificity | When tested in competitive ELISA, the anti-Kynurenic polyclonal antibody did not show any significant cross reactivity with Quinaldic and Xanthurenic conjugates. |
| Lot number | 140401 |
Storage
| Form | Liquid |
| Purity | Purified anti-serum |
| Storage | Store at +4°C for short term (1-2 weeks). Aliquot and store at -20°C for long term. Avoid repeated freeze / thaw cycles |
| Material safety datasheet | Download MSDS |
Protocols
| Immunohistochemistry (IHC) | Dilute at 1:200-1:2000. Perform heat antigen retrieval (pH=6) before initiating IHC staining protocol on paraffin-embedded and frozen sections |
| Comments | Optimal working dilutions must be determined by the end-user |
| Restrictions | For research use only |
References
Antibody not yet cited. Submit an article and get a 10% discount.
Selected articles on Kynurenic acid:
- Justinova Z et al. Reducing cannabinoid abuse and preventing relapse by enhancing endogenous brain levels of kynurenic acid. Nat Neurosci. 2013 Nov;16(11):1652-61. doi: 10.1038/nn.3540. Epub 2013 Oct 13.
- StoneTW, Stoy N, Darlington LG. An expanding range of targets for kynureninemetabolites of tryptophan. Trends Pharmacol Sci. 2013 Feb;34(2):136-43.doi: 10.1016/j.tips.2012.09.006. Epub 2012 Nov 1.
- Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci. 2012 Jul;13(7):465-77. doi: 10.1038/nrn3257.
- Moroni F, Cozzi A, Sili M, Mannaioni G. Kynurenic acid: a metabolite with multiple actions and multiple targets in brain and periphery. J Neural Transm. 2012 Feb;119(2):133-9. doi: 10.1007/s00702-011-0763-x. Epub 2012 Jan 4.
- Linderholm KR et al. Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia. Schizophr Bull. 2012 May;38(3):426-32. doi: 10.1093/schbul/sbq086. Epub 2010 Aug 20.
- Stone TW, Forrest CM, Darlington LG. Kynurenine pathway inhibition as a therapeutic strategy for neuroprotection. FEBS J. 2012 Apr;279(8):1386-97. doi: 10.1111/j.1742-4658.2012.08487.x. Epub 2012 Mar 27.
Technical SupportSubmit a question
No technical question yet. Be the first to ask!TopReviewsSubmit your review
No reviews yet. Thanks for rating this product.Top品牌介绍
我们的重点：针对小分子的抗体ImmuSmol代表“针对小分子的免疫球蛋白[抗体]”。传统抗体只能识别蛋白质等大分子，而ImmuSmol设计并开发能够靶向低分子量实体（<900 Da）的抗体。因此，氨基酸，脂质，糖类，毒素，药物……实际上，任何小分子都可以以高亲和力和特异性来处理。与现有的基于抗体的技术完全兼容，小分子抗体为研究，诊断和治疗开辟了全新的可能性。三大核心应用研究抗体 -ImmuSmol销售经过验证的 一抗，用于细胞和组织中的小分子检测和可视化。定制服务 -ImmuSmol提供针对小分子的抗体，用于研究，诊断和治疗应用。诊断与治疗 -目前正在开发基于专有小分子抗体的三种个性化医学程序。
